Results 131 to 140 of about 452,408 (160)

The complexome contextualizes proteomics data to fingerprint biological states and highlight perturbed functional modules in disease. [PDF]

open access: yesNPJ Syst Biol Appl
Guharoy M   +22 more
europepmc   +1 more source

Genetic and Cellular Studies of Oxidative Stress in Methylmalonic Aciduria (MMA) Cobalamin Deficiency Type C (cblC) With Homocystinuria (MMACHC)

open access: yesHuman Mutation, 2009
Methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC) is the most frequent genetic disorder of vitamin B12 metabolism.
Celia Pérez-Cerdá   +2 more
exaly   +5 more sources

Treatment of Cobalamin C (cblC) Deficiency During Pregnancy

Journal of Inherited Metabolic Disease, 2010
AbstractObjectiveTo report the successful pregnancy of a woman with methylmalonic acidemia and hyperhomocysteinemia, cblC type [cobalamin C (cblC) deficiency] (MIM 277400).MethodRetrospective chart review.ResultsA 24‐year‐old woman presented at 14 weeks gestation with nausea, self‐restricted protein diet, and weight loss.
Grant A Mitchell   +2 more
exaly   +3 more sources

Glutathione metabolism in cobalamin deficiency type C (cblC)

Journal of Inherited Metabolic Disease, 2013
AbstractBackgroundMethylmalonic aciduria with homocystinuria, cblC defect, is the most frequent disorder of vitamin B12 metabolism. CblC patients are commonly treated with a multidrug therapy to reduce metabolite accumulation and to increase deficient substrates.
Anna, Pastore   +8 more
openaire   +2 more sources

Plasma Exosomes From Healthy Individuals Could Protect Against Hippocampal Neuron Injury Induced by MMACHC Variants in Cobalamin (cblC) Deficiency

SSRN Electronic Journal, 2021
Background: Methylmalonic acid (MMA) combined with homocysteine (HCY) limits the survival and function of neurons during the development of cobalamin C (cblC) deficiency, yet no effective medication currently exists to ameliorate the damage. Methods: We designed a novel second-tier assay utilizing ultraperformance liquid chromatography-tandem mass ...
Zhou Wei   +8 more
openaire   +1 more source

Would, early, versus late hydroxocobalamin dose intensification treatment, prevent cognitive decline, macular degeneration and ocular disease, in 5 patients with early-onset cblC deficiency?

Molecular Genetics and Metabolism, 2023
In early-onset (EO) cblC deficiency (MMACHC), hydroxocobalamin dose-intensification (OHCBL-DI) improved biochemical and clinical outcome. In mammals, Cobalamin is reduced, in a reaction mediated by MMACHC. Pathogenic variants in MMACHC disrupt the synthesis pathway of methyl-cobalamin (MetCbl) and 5'-deoxy-adenosyl-cobalamin (AdoCbl), cofactors for ...
Scalais, Emmanuel   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy